Rhumbline Advisers Has $1.38 Million Position in Novavax, Inc. (NASDAQ:NVAX)
Rhumbline Advisers lifted its position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 3.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 215,413 shares of the biopharmaceutical company’s stock after buying an additional 6,949 shares during the period. Rhumbline […]
